Ronald E. Bruehlman
Director · GoodRx Holdings, Inc.
Individual
- 2024
- Jun 18, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ronald E. Bruehlman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ari Bousbib - $38.55M in IQV purchases and sales in the last 12 months
- FRANCISCO PARTNERS IV, L.P. - $9.68M in GDRX purchases and sales in the last 12 months
- Eric Sherbet - $2.12M in IQV purchases and sales in the last 12 months
- W. Richard Staub - $1.28M in IQV purchases and sales in the last 12 months
- James G. Berkshire - $697K in IQV purchases and sales in the last 12 months
- Bhavik Patel - $436K in IQV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ronald E. Bruehlman?
Ronald E. Bruehlman is a corporate insider, tracked as Director of GoodRx Holdings, Inc. (GDRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Ronald E. Bruehlman last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 5 filings going back to 2024.
